Diabetic Neuropathy
📧 Sign up to get email alerts when something new happens for Diabetic Neuropathy.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2024-07-09EMA Authorised: Duloxetine Lilly (duloxetine) — Eli Lilly Nederland B.V.
The European Medicines Agency authorised duloxetine (Lilly) by Eli Lilly Nederland B.V. for neuralgia, diabetic neuropathies, and major depr…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Use of Thermography for the Prevention and Diagnosis of Diabetic Foot
This clinical trial from the University of Seville evaluates thermography for the prevention and diagnosis of diabetic foot. The study is cu…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Treatment for Diabetic Neuropathy Using Repetitive Transcranial Magnetic Stimulation [NA]
A clinical trial update shows a NOT_YET_RECRUITING study evaluating repetitive transcranial magnetic stimulation for diabetic neuropathy, sp…
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: Comparative Effectiveness Of Low Extra-Corporeal Shock Wave Versus Acetylcholine Iontophoresis On Type2 Diabetic Neuropathy [NA]
A clinical trial update describing a comparative effectiveness study of low extracorporeal shock wave therapy versus acetylcholine iontophor…
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: US & HILT Comparative Effect on Neuropathic Pain, Strength & QOF in Diabetic Foot [NA]
A clinical trial update shows a US and HILT comparative study assessing neuropathic pain, strength, and quality of life in diabetic foot pat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-06-24Clinical Trial Update: Neuroprosthetic Device for Improving Issues Caused by Diabetic Neuropathy With Specifically Designed Neural Stimulation [NA]
A clinical trial is recruiting to test a neuroprosthetic neural stimulation device aimed at improving symptoms of diabetic peripheral neurop…
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: Effects of Foot Muscle Strengthening in Daily Activity in Diabetic Neuropathic Patients [NA]
Completed clinical trial evaluating the effect of foot muscle strengthening on daily activity in patients with diabetic neuropathy; results …
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions [Phase 4]
Phase 4 trial evaluating lidocaine patch 5% alone, gabapentin alone, and combination for relief of peripheral neuropathic pain.
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: A Study of the Effectiveness And Safety Of Lidoderm® As Add-On Treatment in Patients With Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back Pain [Phase 4]
Phase 4 trial evaluating Lidoderm as add-on therapy for postherpetic neuralgia, diabetic neuropathy, or low back pain; study completed.
-
FDA approval · 2023-12-13FDA Approved: LYRICA CR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for LYRICA CR (pregabalin) filed by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2023-11-24Clinical Trial Update: Empagliflozin in Treatment of Peripheral Diabetic Neuropathy [Phase 1, Phase 2]
Clinical trial update for empagliflozin in peripheral diabetic neuropathy across Phase 1 and Phase 2, with completed status.
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: Clinical Study Evaluating the Safety and Efficacy of Roflumilast in Type 2 Diabetic Patients With Diabetic Neuropathy [Phase 3]
Clinical trial evaluating safety and efficacy of roflumilast in adults with type 2 diabetes and diabetic neuropathy has completed Phase 3.
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes [Phase 2]
A Phase 2 trial evaluating intravenous immunoglobulin therapy for treatment-induced diabetic neuropathy was terminated, and results have bee…
-
FDA approval · 2023-07-12FDA Approved: PREGABALIN — Original Application (Cadila Pharmaceuticals Limited)
FDA approved Cadila Pharmaceuticals Limited's original application for pregabalin, enabling a generic version of the drug.
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: Extension of Phase 3 Gene Therapy for Painful Diabetic Neuropathy [Phase 3]
Extension of a Phase 3 gene therapy trial for painful diabetic neuropathy; the study completed and results were posted in March 2023.
-
CLINICAL_TRIALS trial_result · 2022-08-22Clinical Trial Update: Phase 3 Gene Therapy for Painful Diabetic Neuropathy [Phase 3]
Phase 3 clinical trial results for Helixmith's VM202 gene therapy in painful diabetic neuropathy have been posted after the study was comple…
-
CLINICAL_TRIALS trial_result · 2022-08-08Clinical Trial Update: Effect of High-Dose NAC on Patients With DPN [Phase 4]
A Phase 4 clinical trial update studying the effect of high-dose N-acetylcysteine (NAC) on patients with diabetic neuropathies; current stat…
-
CLINICAL_TRIALS trial_result · 2022-06-13Clinical Trial Update: Study of CBME in the Relief of Painful Diabetic Neuropathy [Phase 2]
Phase 2 clinical trial update on CBME for relief of Painful Diabetic Neuropathy has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: Omnitram Safety and Efficacy in the Treatment of Diabetic Neuropathy [Phase 2]
Phase 2 trial update on Omnitram for diabetic neuropathy, reporting safety and efficacy results.
-
CLINICAL_TRIALS trial_result · 2021-09-14Clinical Trial Update: Study With Two Capsaicin Topic Treatments in Diabetic Neuropathy. [Phase 3]
A Phase 3 clinical trial evaluating two capsaicin topical treatments for painful diabetic neuropathy has been completed.
-
CLINICAL_TRIALS trial_result · 2021-08-04Clinical Trial Update: Effect of Transcutaneous Electrical Nerve Stimulation in Diabetic Neuropathy [Phase 3]
A Phase 3 clinical trial evaluating transcutaneous electrical nerve stimulation for diabetic neuropathy has been terminated.
-
EMA withdrawal · 2021-06-22EMA Withdrawn: Nodetrip (previously Xeristar) (duloxetine) — Esteve Pharmaceuticals, S.A.
The EMA has withdrawn Nodetrip (duloxetine) from Esteve Pharmaceuticals, covering indications in anxiety disorders, major depressive disorde…
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: A Study on the Efficacy and Safety of Gabapentin in the Treatment of Patients With Painful Diabetic Neuropathy [Phase 4]
Phase 4 trial update on gabapentin for painful diabetic neuropathy assessing efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy [Phase 4]
Phase 4 trial update on pregabalin for pain due to diabetic peripheral neuropathy (completed).
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: A Study To Evaluate Pregabalin In Patients With Painful Diabetic Peripheral Neuropathy (DPN) [Phase 4]
Phase 4 clinical trial evaluating pregabalin for painful diabetic neuropathy has been completed.